These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7973470)

  • 21. Flupenthixol in relapse prevention in schizophrenics with comorbid alcoholism: results from an open clinical study.
    Soyka M; Aichmüller C; v Bardeleben U; Beneke M; Glaser T; Hornung-Knobel S; Wegner U
    Eur Addict Res; 2003 Apr; 9(2):65-72. PubMed ID: 12644732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Family groups and family self-help groups for schizophrenic patients. Concepts, establishment, problems in implementation].
    Schulze-Mönking H; Stricker K; Rook A; Buchkremer G
    Psychiatr Prax; 1989 Jan; 16(1):28-35. PubMed ID: 2710856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychoeducational family therapy for schizophrenia: a review essay.
    Steinglass P
    Psychiatry; 1987 Feb; 50(1):14-23. PubMed ID: 3575550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic benefit of a registered psychoeducation program on treatment adherence, objective and subjective quality of life: French pilot study for schizophrenia].
    Sauvanaud F; Kebir O; Vlasie M; Doste V; Amado I; Krebs MO
    Encephale; 2017 May; 43(3):235-240. PubMed ID: 27658989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Group psychoeducational intervention in relatives of patients suffering from schizophrenia].
    Palli A; Kalantzi-Azizi A; Ploumpidis DN; Kontoangelos K; Economou M
    Psychiatriki; 2015; 25(4):243-54. PubMed ID: 26709990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomised-control trial of family intervention for 78 first-episode male schizophrenic patients. An 18-month study in Suzhou, Jiangsu.
    Zhang M; Wang M; Li J; Phillips MR
    Br J Psychiatry Suppl; 1994 Aug; (24):96-102. PubMed ID: 7946238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting medication-free treatment response in acute psychosis: cross-validation from the Finnish Need-Adapted Project.
    Bola JR; Lehtinen K; Aaltonen J; Räkköläinen V; Syvälahti E; Lehtinen V
    J Nerv Ment Dis; 2006 Oct; 194(10):732-9. PubMed ID: 17041284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Psychosis Project: outcome and cost-effectiveness of a psychoeducational treatment programme for schizophrenic adolescents.
    Rund BR; Moe L; Sollien T; Fjell A; Borchgrevink T; Hallert M; Naess PO
    Acta Psychiatr Scand; 1994 Mar; 89(3):211-8. PubMed ID: 7909978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is memory impairment a rate limiter in cognitive behavioural therapy for chronic schizophrenia?
    Penadés R; Catalán R; Pujol N; Puig O; Guarch J; Masana G; Navarro V; Gastó C
    Psychother Psychosom; 2010; 79(2):129-30. PubMed ID: 20090401
    [No Abstract]   [Full Text] [Related]  

  • 30. A prospective, open-label study to evaluate symptomatic remission in schizophrenia with risperidone long-acting injectable in Korea.
    Lee NY; Kim SH; Cho SJ; Chung YC; Jung IK; Kim CY; Kim DH; Lee DG; Lee YH; Lim WJ; Na YS; Shin SE; Woo JM; Yoon JS; Yoon BH; Ahn YM; Kim YS
    Int Clin Psychopharmacol; 2014 Sep; 29(5):279-87. PubMed ID: 24583566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How representative of everyday clinical populations are schizophrenia patients enrolled in clinical trials?
    Riedel M; Strassnig M; Müller N; Zwack P; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2005 Apr; 255(2):143-8. PubMed ID: 15549345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Randomized controlled trial on effectiveness of the community re-entry program to inpatients with schizophrenia spectrum disorder, centering around acquisition of illness self-management knowledge].
    Naoki K; Nobuo A; Emi I
    Seishin Shinkeigaku Zasshi; 2003; 105(12):1514-31. PubMed ID: 15027310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient functioning and family burden in a controlled, real-world trial of family psychoeducation for schizophrenia.
    Magliano L; Fiorillo A; Malangone C; De Rosa C; Maj M
    Psychiatr Serv; 2006 Dec; 57(12):1784-91. PubMed ID: 17158495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of an open-door policy combined with a structured activity programme on the residual symptoms of schizophrenic in-patients. A six-month randomised controlled trial in Yanbian, Jilin.
    Jin Z
    Br J Psychiatry Suppl; 1994 Aug; (24):52-7. PubMed ID: 7946232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of treatment refractory schizophrenia.
    Morrison DP
    Br J Psychiatry Suppl; 1996 Dec; (31):15-20. PubMed ID: 8968651
    [No Abstract]   [Full Text] [Related]  

  • 36. Predictors of relapse in the year after hospital discharge among patients with schizophrenia.
    Schennach R; Obermeier M; Meyer S; Jäger M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Seemüller F; Möller HJ; Riedel M
    Psychiatr Serv; 2012 Jan; 63(1):87-90. PubMed ID: 22227766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Why do indiviuals with schizophrenia drop out of observational clinical trials?
    Hofer A; Radner V; Edlinger M; Kemmler G; Rettenbacher MA; Fleischhacker WW
    Psychiatry Res; 2017 Oct; 256():1-5. PubMed ID: 28609646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reducing the dose of depot neuroleptics in stable schizophrenia.
    Dale R; Longdon M; Seeman MV
    J Psychiatry Neurosci; 1994 Jul; 19(4):278-81. PubMed ID: 7918349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immigrant families coping with schizophrenia. Behavioral family intervention v. case management with a low-income Spanish-speaking population.
    Telles C; Karno M; Mintz J; Paz G; Arias M; Tucker D; Lopez S
    Br J Psychiatry; 1995 Oct; 167(4):473-9. PubMed ID: 8829715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs.
    Liu-Seifert H; Adams DH; Kinon BJ
    BMC Med; 2005 Dec; 3():21. PubMed ID: 16375765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.